Great paper !!! had a busy day and just got to read it with

New Post Public Reply Private Reply Replies (0) Message Board
TechGuru
667
Great paper !!! had a busy day and just got to read it with a good cup of coffee.

Some of my highlights:

The restoration to healthy levels of IL-6 and the restoration of the CD4/CD8 ratio for the majority of patients is just amazing.

The plasma viral load is going down for all patients, would like to se what do they look like after day 21.

"In line with the decrease of IL-6 protein levels observed in plasma, IL-6 transcripts were downregulated between day 0 and day 7 in monocytes, consistent with reports of monocyte/macrophages repolarization following CCR5 blockade"


Quote:
Recent studies have found that a significant number of COVID-19 patients experience increased risks of strokes, blood clots and other thromboembolic events21. Platelet activation, which leads to the initiation of the coagulation cascade, can be triggered by chemokines including CCL5, suggesting that leronlimab treatment may be beneficial beyond its immunomodulatory effects on inflammation and hemostasis in COVID-19 patients.


The conclusion:

Quote:
In summary, we show here for the first time, involvement of the CCL5-CCR5 axis in the pathology of SARS-CoV-2, and present evidence that inhibition of CCL5 activity via CCR5 blockade represents a novel therapeutic strategy for COVID-19 with both immunologic and virologic implications.


it would take a monkey not to understand that this has been proven beyond any doubt !!!

So we have:

Modulation of hemostasis
Immunomodulatory effects on inflammation (restoration of T cell lymhocytopenia).
Monocyte/macrophages repolarization
Reduced COVID plasma viremia

Who can do this ??? Who has a drug ready that can do this ?? Who has demonstrated that can do this ???

How much is this worth(in human lives) ??

Are there any doubts ??? Not on my mind. Would like to see more information on the hemostasis front and latter data on the plasma viral load but, in general, this study "throw it out of the park".

If, afer reading this paper, anybody has any doubts about Leronlimab role in COVID, you should not be here and should not be investing in CYDY or otherwise.



CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GFT's Banking Leader Tag Puts Execution Risks Into Focus

Updated Category News Views 82

A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 51

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 139

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 65

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 101

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Specialized Metal Makers Become the New M&A Prize Again

Updated Category News Views 5

A forgotten heat-treatment line can suddenly be worth more than a shiny new mill when buyers realize nobody can duplicate its certifications, workforce, and customer approvals overnight. That is the basic truth sitting underneath BGL's Nov. 19, 2026 assessment of the U.S. metals market. The easy headline is consolidation. The useful takeaway is much narrower: specialized...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 27

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 58

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 83

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
McDonald's Franchise Wage Suit Puts Compliance on Notice

Updated Category News Views 51

Payroll sloppiness can turn a cheap burger shift into an expensive courtroom problem fast. Zakay Law Group, APLC has filed a proposed class action in Alameda County Superior Court against a long list of McDonald's franchise-related entities, alleging workers were not paid all wages due under California law. The case, 26CV218760, is pending, not proven, and that...

Continue Reading

Top 5 Most Recently Viewed Articles

Degree Deodorant Shakes Up NYC Subway with Savvy Ads

Updated Category News Views 28

Sweat and Laughter in the Big Apple Here we go again, folks! Degree Deodorant, the top dog in the antiperspirant world, is spicing up New York City's subway stations this summer. Now, I know what you're thinking: subway rides and deodorant—what a combo! But trust me, their new advertising campaign is a stroke of genius. It's inspired by those memorable, sweaty summer...

Continue Reading
Cupid's Senior Squad Ready to Share Dating Wisdom

Updated Category News Views 91

Cupid's Senior Squad Ready to Share Dating Wisdom As Valentine's Day approaches, many look for meaningful advice on relationships and dating. Instead of relying on dating apps or self-proclaimed experts, you can trust the Cupid Senior Squad to provide wisdom gained over decades of love. Located at RiverSpring Living, this dedicated team is geared up to answer your...

Continue Reading
Intl Flavors & Fragrances Short Interest Insights and Trends

Updated Category News Views 141

Understanding Short Interest for Intl Flavors & Fragrances International Flavors & Fragrances Inc (NASDAQ: IFF) has been experiencing notable fluctuations in its short interest, a key metric for investors. Recently, the company reported a decline of 5.37% in its short percent of float since the last update. Currently, 5.42 million shares are sold short, which constitutes...

Continue Reading
Exploring the Growth of RFID Tags Market Towards 2032

Updated Category News Views 161

RFID Tags Market Size and Growth Projections The RFID tags market is on the rise, with projections indicating a market size of USD 29.05 billion by 2032. This growth stems from technological advancements and an increase in the adoption of RFID technology across different sectors. The market was valued at USD 12.42 billion in 2023, showcasing a compound annual growth rate...

Continue Reading
DataMesh Robotics Revolutionizes Industrial AI Training

Updated Category News Views 188

DataMesh Robotics Unveils a New Era in Industrial AI Training DataMesh, a prominent provider of digital twin technology and spatial intelligence solutions, has recently introduced DataMesh Robotics. This innovation is tailored to meet the needs of industrial and facility management scenarios, primarily through the use of embodied AI. The heart of this solution lies in the...

Continue Reading